Oligomeric Amyloid Beta Associates with Postsynaptic Densities and Correlates with Excitatory Synapse Loss Near Senile Plaques

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2009 Feb 21

PMID 19228947

Citations 453

Authors

Robert M Koffie

Melanie Meyer-Luehmann

Tadafumi Hashimoto

Kenneth W Adams

Matthew L Mielke

Monica Garcia-Alloza

Kristina D Micheva

Stephen J Smith

M Leo Kim

Virginia M Lee

Bradley T Hyman

Tara L Spires-Jones

Affiliations

Soon will be listed here.

Abstract

Synapse loss correlates with a cognitive decline in Alzheimer's disease (AD), but whether this is caused by fibrillar deposits known as senile plaques or soluble oligomeric forms of amyloid beta (Abeta) is controversial. By using array tomography, a technique that combines ultrathin sectioning of tissue with immunofluorescence, allowing precise quantification of small structures, such as synapses, we have tested the hypothesis that oligomeric Abeta surrounding plaques contributes to synapse loss in a mouse model of AD. We find that senile plaques are surrounded by a halo of oligomeric Abeta. Analysis of >14,000 synapses (represented by PSD95-stained excitatory synapses) shows that there is a 60% loss of excitatory synapses in the halo of oligomeric Abeta surrounding plaques and that the density increases to reach almost control levels in volumes further than 50 microm from a plaque in an approximately linear fashion (linear regression, r(2) = 0.9; P < 0.0001). Further, in transgenic cortex, microdeposits of oligomeric Abeta associate with a subset of excitatory synapses, which are significantly smaller than those not in contact with oligomeric Abeta. The proportion of excitatory synapses associated with Abeta correlates with decreasing density (correlation, -0.588; P < 0.0001). These data show that senile plaques are a potential reservoir of oligomeric Abeta, which colocalizes with the postsynaptic density and is associated with spine collapse, reconciling the apparently competing schools of thought of "plaque" vs. "oligomeric Abeta" as the synaptotoxic species in the brain of AD patients.

Citing Articles

Lower expression of neuronal isoform in vulnerable excitatory neurons increases risk in Alzheimer's disease.

Ranganathan R, Li S, Sapozhnikov G, Wang S, Song Y J Alzheimers Dis Rep. 2025; 9:25424823241296018.

PMID: 40034505 PMC: 11864243. DOI: 10.1177/25424823241296018.

Isotope Encoded Spatial Biology Identifies Amyloid Plaque-Age-Dependent Structural Maturation, Synaptic Loss, and Increased Toxicity.

Wood J, Wood J, Dulewicz M, Ge J, Stringer K, Szadziewska A Res Sq. 2025; .

PMID: 39975899 PMC: 11838767. DOI: 10.21203/rs.3.rs-5829037/v1.

Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ/Aβ ratios, neurofilament light and tau in Alzheimer's disease model mice.

Andersson E, Lindblom N, Janelidze S, Salvado G, Gkanatsiou E, Soderberg L Nat Aging. 2025; .

PMID: 39939821 DOI: 10.1038/s43587-025-00810-8.

Microglia degrade Alzheimer's amyloid-beta deposits extracellularly via digestive exophagy.

Jacquet R, Gonzalez Ibanez F, Picard K, Funes L, Khakpour M, Gouras G Cell Rep. 2024; 43(12):115052.

PMID: 39644493 PMC: 11760508. DOI: 10.1016/j.celrep.2024.115052.

Animal models of Alzheimer's disease: Current strategies and new directions.

Wang Q, Zhu B, Lei P Zool Res. 2024; 45(6):1385-1407.

PMID: 39572020 PMC: 11668949. DOI: 10.24272/j.issn.2095-8137.2024.274.

References

Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

Micheva K, Smith S . Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits. Neuron. 2007; 55(1):25-36. PMC: 2080672. DOI: 10.1016/j.neuron.2007.06.014. View

Harris K, Stevens J . Dendritic spines of CA 1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics. J Neurosci. 1989; 9(8):2982-97. PMC: 6569708. View

Lassmann H, Fischer P, Jellinger K . Synaptic pathology of Alzheimer's disease. Ann N Y Acad Sci. 1993; 695:59-64. DOI: 10.1111/j.1749-6632.1993.tb23028.x. View

Lesne S, Koh M, Kotilinek L, Kayed R, Glabe C, Yang A . A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006; 440(7082):352-7. DOI: 10.1038/nature04533. View

Zhou Q, Homma K, Poo M . Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron. 2004; 44(5):749-57. DOI: 10.1016/j.neuron.2004.11.011. View

Thevenaz P, Ruttimann U, Unser M . A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process. 2008; 7(1):27-41. DOI: 10.1109/83.650848. View

Lee E, Leng L, Zhang B, Kwong L, Trojanowski J, Abel T . Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. J Biol Chem. 2005; 281(7):4292-9. DOI: 10.1074/jbc.M511018200. View

Lacor P, Buniel M, Furlow P, Clemente A, Velasco P, Wood M . Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci. 2007; 27(4):796-807. PMC: 6672917. DOI: 10.1523/JNEUROSCI.3501-06.2007. View

10.

Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S . AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron. 2006; 52(5):831-43. PMC: 1850952. DOI: 10.1016/j.neuron.2006.10.035. View

11.

Nusser Z, Lujan R, Laube G, Roberts J, Molnar E, Somogyi P . Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus. Neuron. 1998; 21(3):545-59. DOI: 10.1016/s0896-6273(00)80565-6. View

12.

Lambert M, Barlow A, Chromy B, Edwards C, Freed R, Liosatos M . Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998; 95(11):6448-53. PMC: 27787. DOI: 10.1073/pnas.95.11.6448. View

13.

Spires-Jones T, Mielke M, Rozkalne A, Meyer-Luehmann M, de Calignon A, Bacskai B . Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease. Neurobiol Dis. 2008; 33(2):213-20. PMC: 2672591. DOI: 10.1016/j.nbd.2008.10.011. View

14.

Lesne S, Kotilinek L, Ashe K . Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience. 2007; 151(3):745-9. PMC: 2677385. DOI: 10.1016/j.neuroscience.2007.10.054. View

15.

Shankar G, Li S, Mehta T, Garcia-Munoz A, Shepardson N, Smith I . Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med. 2008; 14(8):837-42. PMC: 2772133. DOI: 10.1038/nm1782. View

16.

Walsh D, Klyubin I, Fadeeva J, Cullen W, Anwyl R, Wolfe M . Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002; 416(6880):535-9. DOI: 10.1038/416535a. View

17.

Takahashi R, Almeida C, Kearney P, Yu F, Lin M, Milner T . Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci. 2004; 24(14):3592-9. PMC: 6729733. DOI: 10.1523/JNEUROSCI.5167-03.2004. View

18.

Cleary J, Walsh D, Hofmeister J, Shankar G, Kuskowski M, Selkoe D . Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci. 2004; 8(1):79-84. DOI: 10.1038/nn1372. View

19.

Jankowsky J, Slunt H, Ratovitski T, Jenkins N, Copeland N, Borchelt D . Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng. 2001; 17(6):157-65. DOI: 10.1016/s1389-0344(01)00067-3. View

20.

Coleman P, Yao P . Synaptic slaughter in Alzheimer's disease. Neurobiol Aging. 2003; 24(8):1023-7. DOI: 10.1016/j.neurobiolaging.2003.09.001. View